These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2482949)

  • 1. Inhibition of angiotensin converting enzyme by N-terminal fragments of substance P.
    Rogerson FM; Livett BG; Scanlon D; Mendelsohn FA
    Neuropeptides; 1989; 14(4):213-7. PubMed ID: 2482949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Substance P inhibition of the activity of the angiotensin-converting enzyme from human blood serum].
    Komissarova NV; Siems WE; Gomazkov OA; Oehme P; Jentzsch KD
    Biull Eksp Biol Med; 1982 Jun; 93(6):3-5. PubMed ID: 6180780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of substance P and its fragments on the activity of angiotensin converting enzyme].
    Siems WE; Komissarova NV; Gomazkov OA; Heder G
    Patol Fiziol Eksp Ter; 1984; (3):79-81. PubMed ID: 6206462
    [No Abstract]   [Full Text] [Related]  

  • 4. The substance P(1-7) fragment is a potent modulator of substance P actions in the brain.
    Herrera-Marschitz M; Terenius L; Sakurada T; Reid MS; Ungerstedt U
    Brain Res; 1990 Jun; 521(1-2):316-20. PubMed ID: 1698511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of canine lung angiotensin converting enzyme by substance P.
    Verma PS; Adams RG; Miller RL
    Eur J Pharmacol; 1982 Dec; 86(2):275-7. PubMed ID: 6186502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of substance P and substance P--sequences on immunocompetent cells.
    Paegelow I; Werner H; Bienert M; Oehme P
    Pharmazie; 1989 Feb; 44(2):145-6. PubMed ID: 2473479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.
    Inada Y; Terashita Z; Imura Y; Tanabe M; Nishikawa K; Kikuchi S
    Jpn J Pharmacol; 1986 Sep; 42(1):99-108. PubMed ID: 3025487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
    Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
    Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranigral substance P modulation of striatal dopamine: interaction with N-terminal and C-terminal substance P fragments.
    Reid MS; Herrera-Marschitz M; Terenius L; Ungerstedt U
    Brain Res; 1990 Sep; 526(2):228-34. PubMed ID: 1701682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway responses to substance P and substance P fragments in the guinea pig.
    Shore SA; Drazen JM
    Pulm Pharmacol; 1988; 1(3):113-8. PubMed ID: 2485179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors.
    Subissi A; Criscuoli M; Sardelli G; Guelfi M; Giachetti A
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):139-46. PubMed ID: 1383623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
    Ahluwalia A; Giuliani S; Maggi CA
    Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous urocortin on angiotensin-converting enzyme in rats.
    Yang C; Xu Y; Mendez T; Wang F; Yang Q; Li S
    Vascul Pharmacol; 2006 Apr; 44(4):238-46. PubMed ID: 16488667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats.
    Stegbauer J; Oberhauser V; Vonend O; Rump LC
    Cardiovasc Res; 2004 Feb; 61(2):352-9. PubMed ID: 14736552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of substance P and partial sequences of this compound on angiotensin I converting enzyme activity].
    Siems WE; Komissarowa NW; Gomaskow OA; Oehme P; Jentzsch KD; Chernukh AM
    Pharmazie; 1983 Apr; 38(4):256-7. PubMed ID: 6191346
    [No Abstract]   [Full Text] [Related]  

  • 17. An antagonist of substance P N-terminal fragments, D-substance P(1-7), reveals that both nociceptive and antinociceptive effects are induced by substance P N-terminal activity during noxious chemical stimulation.
    Goettl VM; Larson AA
    Brain Res; 1998 Jan; 780(1):80-5. PubMed ID: 9473599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of aerosolised substance P on lung resistance in guinea-pigs: a comparison between inhibition of neutral endopeptidase and angiotensin-converting enzyme.
    Lötvall JO; Skoogh BE; Barnes PJ; Chung KF
    Br J Pharmacol; 1990 May; 100(1):69-72. PubMed ID: 1695534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance P-induced release of Met5-enkephalin from striatal and periaqueductal gray slices.
    Del Río J; Naranjo JR; Yang HY; Costa E
    Brain Res; 1983 Nov; 279(1-2):121-6. PubMed ID: 6196090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemorphins derived from hemoglobin have an inhibitory action on angiotensin converting enzyme activity.
    Lantz I; Glämsta EL; Talbäck L; Nyberg F
    FEBS Lett; 1991 Aug; 287(1-2):39-41. PubMed ID: 1652464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.